Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$3.99 USD
+0.23 (5.98%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $3.98 -0.01 (-0.25%) 4:32 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Earnings News For STRO
-
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
-
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
-
Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
-
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
-
Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates
-
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Misses Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates
-
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy?
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Misses Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy?
-
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates
-
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates
-
Will Sutro Biopharma, Inc. (STRO) Report Negative Q2 Earnings? What You Should Know
-
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Lags Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates
-
Will Sutro Biopharma, Inc. (STRO) Report Negative Q2 Earnings? What You Should Know